We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Ethan Allen Interiors
ETD
$606M
| $428K | ﹤0.01% |
16,210
-638
| -4% | -$18.7K |
|
2277
Team
TISI
$80.6M
| $427K | ﹤0.01% |
1,330
-16
| -1% | -$6.85K |
|
|
EBIX
2278
DELISTED
Ebix Inc
EBIX
| $427K | ﹤0.01% |
17,097
-1,493
| -8% | -$44.2K |
|
|
CBB
2279
DELISTED
Cincinnati Bell Inc.
CBB
| $427K | ﹤0.01% |
27,402
-834
| -3% | -$15.1K |
|
|
ECHO
2280
EchoStar
ECHO
$24.9B
| $426K | ﹤0.01% |
12,225
+4,464
| +58% | +$165K |
|
|
CVGW
2281
DELISTED
Calavo Growers
CVGW
| $425K | ﹤0.01% |
9,529
-190
| -2% | -$9.91K |
|
2282
Consumer Portfolio Services
CPSS
$207M
| $424K | ﹤0.01% |
85,190
+29,843
| +54% | +$171K |
|
2283
Sonic Automotive
SAH
$3.31B
| $424K | ﹤0.01% |
20,763
-998
| -5% | -$22.3K |
|
|
INSY
2284
DELISTED
Insys Therapeutics, Inc.
INSY
| $424K | ﹤0.01% |
14,911
+124
| +0.8% | +$4.56K |
|
2285
Greenlight Captial
GLRE
$586M
| $423K | ﹤0.01% |
18,990
-515
| -3% | -$13.5K |
|
|
UBNK
2286
DELISTED
United Financial Bancorp, Inc.
UBNK
| $423K | ﹤0.01% |
32,418
-707
| -2% | -$9.29K |
|
|
BNCN
2287
DELISTED
BNC Bancorp
BNCN
| $423K | ﹤0.01% |
19,041
+2,367
| +14% | +$50.6K |
|
2288
Globalstar
GSAT
$10.2B
| $422K | ﹤0.01% |
17,922
-4,427
| -20% | -$125K |
|
2289
HubSpot
HUBS
$12.2B
| $422K | ﹤0.01% |
9,092
-377
| -4% | -$18.5K |
|
2290
MacroGenics
MGNX
$245M
| $422K | ﹤0.01% |
19,723
-55,153
| -74% | -$1.73M |
|
|
DEL
2291
DELISTED
Deltic Timber
DEL
| $422K | ﹤0.01% |
7,059
-293
| -4% | -$18.8K |
|
2292
Universal Electronics
UEIC
$58.1M
| $421K | ﹤0.01% |
10,024
-499
| -5% | -$23.8K |
|
|
AFFX
2293
DELISTED
Affymetrix Inc
AFFX
| $421K | ﹤0.01% |
49,310
-2,388
| -5% | -$23.9K |
|
|
CALY
2294
Callaway Golf Company
CALY
$3.28B
| $420K | ﹤0.01% |
50,248
-1,204
| -2% | -$10.5K |
|
|
HZNP
2295
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $420K | ﹤0.01% |
21,184
-471,054
| -96% | -$14.9M |
|
2296
Harte-Hanks
HHS
$16.3M
| $419K | ﹤0.01% |
11,867
+8,599
| +263% | +$388K |
|
2297
Agios Pharmaceuticals
AGIO
$2.14B
| $418K | ﹤0.01% |
5,916
+4,335
| +274% | +$424K |
|
2298
Barnes & Noble Education
BNED
$451M
| $418K | ﹤0.01% |
+329
| New | +$426K |
|
2299
GATX Corp
GATX
$6.6B
| $418K | ﹤0.01% |
9,464
+3,818
| +68% | +$189K |
|
|
FPO
2300
DELISTED
First Potomac Realty Trust
FPO
| $417K | ﹤0.01% |
37,953
-2,309
| -6% | -$25.3K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.